Trading Halt
Released
Released
Announcement PDF
Market Announcement
15 July 2024
Alterity Therapeutics Limited (ASX: ATH) – Trading Halt
Description
The securities of Alterity Therapeutics Limited (‘ATH’) will be placed in trading halt at the request of ATH,
pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt
until the earlier of the commencement of normal trading on Wednesday, 17 July 2024 or when the
announcement is released to the market.
Issued by
ASX Compliance
15 July 2024
ASX Limited
Market Announcement 1/1
ASX Customer Service Centre 131 279 | asx.com.au
15 July 2024
Melissa Kostopoulos
Compliance Adviser, Listings Compliance (Melbourne)
ASX Compliance Pty Ltd
Level 50, South Tower, Rialto
525 Collins St
Melbourne VIC 3000
By email:
TradingHaltsMelbourne@asx.com.au
ListingsComplianceMelbourne@asx.com.au
Dear Melissa
Request for a trading halt – Alterity Therapeutics Limited
In accordance with ASX Listing Rule 17.1, Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (the
Company) requests that its securities be placed into an immediate trading halt pending an
announcement in relation to new data from an ATH434 clinical trial.
The Company requests that trading in its securities be halted until after the expected announcement is
made or until the market opens on Wednesday, 17 July 2024, whichever is the earlier.
The Company is not aware of any reason why this trading halt request should not be granted or of any
other information necessary to inform the market about the trading halt.
Please contact me if you require any further information.
Yours sincerely
Phillip Hains
Company Secretary
Alterity Therapeutics Limited ABN 37 080 699 065
Level 14, 350 Collins Street, Melbourne, VIC 3000 Australia
T: +61 (0)3 9349 4906 | www.alteritytherapeutics.com
Share your feedback
Discover